Novel antiplatelet drugs in clinical development : Platelets: basic mechanisms and translational implicationsUNGERER, Martin; MÜNCH, Götz.Thrombosis and haemostasis. 2013, Vol 110, Num 5, pp 868-875, issn 0340-6245, 8 p.Article

Les antithrombotiques = AntithromboticsLECOMPTE, T.La Lettre du cardiologue. 2003, Num 369, pp 41-43, issn 0761-5035, 3 p., SUPConference Paper

Peripheral ischemia in rabbit hindlimb : effect of cloricromene : VI Meeting of the Inter-Regional Group Emilia-Romagna, Friuli-Venezia Giulia, Trentino-Alto Adige, Veneto of Italian Society of Pharmacology, Ancona, April 23, 1991SALVATICO, E; PARO, M; PROSDOCIMI, M et al.Pharmacological research. 1992, Vol 25, pp 63-64, issn 1043-6618, SUP1Conference Paper

Why have studies of tailored anti-platelet therapy failed so far?SILLER-MATULA, Jolanta M; JILMA, Bernd.Thrombosis and haemostasis. 2013, Vol 110, Num 4, pp 628-631, issn 0340-6245, 4 p.Article

Bon usage des agents antiplaquettairesMT. Médecine thérapeutique. 2012, Vol 18, Num 4, pp 270-277, issn 1264-6520, 8 p.Article

Antiplatelet therapy in the perioperative periodENGELEN, S; SINNAEVE, P; VAN DAMME, H et al.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, pp 139-143, issn 0001-5164, 5 p.Conference Paper

Dyspnoea after antiplatelet agents : the AZD6140 controversySEREBRUANY, V. L; STEBBING, J; ATAR, D et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 3, pp 529-533, issn 1368-5031, 5 p.Article

New antiplatelet agentsSAMAMA, M.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, issn 0001-5164, p. 127Conference Paper

Antiplatelet agents: Current drugs and future trendsMESSMORE, Harry L; JESKE, Walter P; WEHRMACHER, William et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, issn 0889-8588, vi, 87-117 [22 p.]Article

Perioperative Management of Antiplatelet AgentsMOHR, Tyler S; BROUSE, Sara D.Orthopedics (Thorofare). 2012, Vol 35, Num 8, pp 687-691, issn 0147-7447, 5 p.Article

Antiplatelet agents and perioperative bleedingLECOMPTE, Thomas; HARDY, Jean-Francois.Canadian journal of anaesthesia. 2006, Vol 53, Num 6, issn 0832-610X, S103-S112, SUPArticle

AntithrombotiquesFERRARI, E; ROUDAUT, R.Archives des maladies du coeur et des vaisseaux. 2001, Vol 94, Num 11, issn 0003-9683, 128 p., SUPSerial Issue

Antiplatelet effect of butylidenephthalideCHE-MING TENG; WEN-YING CHEN; WUN-CHANG KO et al.Biochimica et biophysica acta. 1987, Vol 924, Num 3, pp 375-382, issn 0006-3002Article

Platelet-inhibitor drugs' role in coronary artery diseaseFUSTER, V; ADAMS, P. C; BADIMON, J. J et al.Progress in cardiovascular diseases. 1987, Vol 29, Num 5, pp 325-346, issn 0033-0620Article

Antiplatelet Drugs: A Review of Their Pharmacology and Management in the Perioperative PeriodHALL, Richard; MAZER, C. David.Anesthesia and analgesia. 2011, Vol 112, Num 2, pp 292-318, issn 0003-2999, 27 p.Article

Place des antiagrégants plaquettaires en cardiologieZAHRAOUI, Maria; ZOUIR, Imane; TAHIRI, A et al.Espérance médicale. 2005, Vol 12, Num 118, pp 375-378, 4 p.Article

Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients' valueWALLENTIN, Lars; HIMMELMANN, Anders; STOREY, Robert F et al.Thrombosis and haemostasis. 2014, Vol 112, Num 1, pp 12-14, issn 0340-6245, 3 p.Article

Antiplatelet actions of 2-{4-[1-(2-chlorophenyl) piperazinyl]} methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compoundYU-AN DING; TZ-CHONG CHOU; JI-WANG CHERN et al.Thrombosis research. 1995, Vol 77, Num 3, pp 291-303, issn 0049-3848Article

Antiagrégants plaquettaires: choix thérapeutique = Antiplatelet agents: therapeutic choiceMORIAU, M.Louvain médical. 1993, Vol 112, Num 4, pp 313-321, issn 0024-6956Conference Paper

Rationale for the development of antithrombotic, antimetastatic and fibrinolytic durgs: a mechanic point of view, international workshop, Montebello PQ, Canada, April 28-May 1, 1987BASTIDA, E. Ed; BUCHANAN, M. R; OFOSU, F. A et al.Seminars in thrombosis and hemostasis. 1988, Vol 14, Num 1, pp 1-132, issn 0094-6176Conference Proceedings

Bon usage des agents antiplaquettairesLa Revue de gériatrie. 2012, Vol 37, Num 8, pp 573-583, issn 0397-7927, 11 p.Article

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 updateCUISSET, Thomas; VALGIMIGIL, Marco; MUDRA, Harald et al.EuroIntervention. 2010, Vol 6, Num 1, pp 39-45, issn 1774-024X, 7 p.Article

Variability of response to antiplatelet therapy : what should we do next?SHANTSILA, Eduard; LIP, Gregory Y. H.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 19-22, issn 0767-3981, 4 p.Article

Antiplaquettaires et hémorragie peropératoire : Anesthésiologie = Antiplatelet drugs and intraoperative haemorrhageCHASSOT, Pierre-Guy; DELABAYS, Alain; RAVUSSIN, Patrick et al.Revue médicale suisse. 2006, Vol 2, Num 88, pp 2684-2687, issn 1660-9379, 4 p.Article

Les nouveaux médicaments antiplaquettaires = Antiplatelet new drugMONTALESCOT, G.Archives des maladies du coeur et des vaisseaux. Pratique. 1998, Num 72, pp 19-20, issn 1261-694XArticle